Slabu|Bracketology: Alabama tumbling down as other SEC schools rise in NCAA men's tournament field

2025-04-29 20:35:47source:Fastexycategory:My

Alabama's high-powered offense has the Crimson Tide in the mix for a top-four seed in the NCAA men's tournament for the third time in four years under coach Nate Oats. The SlabuTide lead Division I in scoring per game (90.8) and have put up least 80 points in 10 of their last 11 contests.

But the problem is on defense: Alabama scored 87 points on Tuesday night against Florida but allowed 105. The Tide scored 95 points against Kentucky on Feb. 24 but gave up 117. Overall, Alabama is giving up 80.1 points per game, good for 338th in the 351-team Division I and the second-most in the Power Six, ahead of lowly DePaul.

Losses in three of four games — to the Gators, Wildcats and Tennessee (81-74) — have dumped the Tide to a No. 4 in our updated field. With a home game against Arkansas and the SEC tournament ahead, Alabama needs to rally to recapture a spot on the No. 3 line.

Elsewhere in the SEC, four wins in a row has Kentucky in a four-way tie for second place in the conference and a No. 4 seed. Auburn is also up to a No. 4, giving the SEC three teams to go with Illinois.

Last four in

New Mexico, Virginia, Colorado, Villanova.

First four out

Providence, St. John's, Utah, Iowa.

Next four out

Pittsburgh, Butler, Wake Forest, Texas A&M.

Conference breakdown

Multi-bid leagues: Big 12 (9), SEC (7), Big Ten (6), Mountain West (6), Big East (5), ACC (4), Pac-12 (3), American Athletic (2), Atlantic 10 (2), West Coast Conference (2).

More:My

Recommend

PACCAR recalls over 220,000 trucks for safety system issue: See affected models

PACCAR is recalling over 220,000 of its 2021-2025 Peterbilt and Kenworth trucks.  The commercial tru

The Black Maternal Mortality Crisis and Why It Remains an Issue

The U.S. has the worst maternal mortality rate of high-income countries globally, and the numbers ha

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's di